Principal Financial Group Portfolio holdings
Principal Financial Group, founded in 1879 as the Bankers Life Association by Edward Temple and headquartered in Des Moines, Iowa, is a global financial services firm specializing in retirement solutions, insurance, and asset management, overseeing more than $709 billion in assets under management as of late 2024. Serving over 62 million customers across individuals, businesses, and institutions, Principal offers 401(k) plans, group insurance (life, disability, dental), annuities, and investment products through its Principal Global Investors arm, with a strong focus on U.S. and international markets like Asia and Latin America. Known for its stability and customer-centric approach, the publicly traded company (NASDAQ: PFG) under CEO Dan Houston has expanded through acquisitions like Wells Fargo’s retirement business in 2019, emphasizing long-term financial security. With a workforce of over 19,000 and a legacy of resilience, Principal remains a trusted name in retirement and wealth management.
Top Buys
| 1 |
S&P Global
SPGI
|
+$343M |
| 2 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$163M |
| 3 |
Entergy
ETR
|
+$126M |
| 4 |
Murphy Oil
MUR
|
+$124M |
| 5 |
DHC
Diversified Healthcare Trust
DHC
|
+$97.2M |
Top Sells
| 1 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$325M |
| 2 |
Becton Dickinson
BDX
|
+$158M |
| 3 |
Crown Castle
CCI
|
+$148M |
| 4 |
TJX Companies
TJX
|
+$136M |
| 5 |
Public Service Enterprise Group
PEG
|
+$122M |
Sector Composition
| 1 | Real Estate | 17.25% |
| 2 | Financials | 16.06% |
| 3 | Technology | 11.28% |
| 4 | Healthcare | 10.24% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
AngioDynamics
ANGO
$445M
| $2.69M | ﹤0.01% |
186,924
+4,689
| +3% | +$67.4K |
|
1602
World Acceptance Corp
WRLD
$904M
| $2.69M | ﹤0.01% |
58,914
+860
| +1% | +$39.2K |
|
1603
BioMarin Pharmaceuticals
BMRN
$10.5B
| $2.68M | ﹤0.01% |
34,402
+4,400
| +15% | +$342K |
|
|
RLYP
1604
DELISTED
RELYPSA INC COM
RLYP
| $2.67M | ﹤0.01% |
144,339
-2,655
| -2% | -$49.1K |
|
|
AFAM
1605
DELISTED
Almost Family Inc
AFAM
| $2.63M | ﹤0.01% |
61,699
+2,077
| +3% | +$88.5K |
|
1606
Forrester Research
FORR
$188M
| $2.61M | ﹤0.01% |
70,761
+2,717
| +4% | +$100K |
|
|
IVC
1607
DELISTED
Invacare Corporation
IVC
| $2.58M | ﹤0.01% |
213,016
+5,133
| +2% | +$62.3K |
|
1608
Nu Skin
NUS
$570M
| $2.58M | ﹤0.01% |
55,763
-3,236
| -5% | -$149K |
|
1609
Metallus
MTUS
$695M
| $2.57M | ﹤0.01% |
267,605
+7,230
| +3% | +$69.5K |
|
|
EGL
1610
DELISTED
Engility Holdings, Inc.
EGL
| $2.57M | ﹤0.01% |
121,543
+3,238
| +3% | +$68.4K |
|
|
AMRI
1611
DELISTED
Albany Molecular Research Inc
AMRI
| $2.57M | ﹤0.01% |
190,939
+6,155
| +3% | +$82.7K |
|
1612
OFG Bancorp
OFG
$1.96B
| $2.57M | ﹤0.01% |
309,016
+8,584
| +3% | +$71.3K |
|
|
TVTY
1613
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.56M | ﹤0.01% |
221,524
+5,980
| +3% | +$69.1K |
|
1614
Haverty Furniture Companies
HVT
$380M
| $2.55M | ﹤0.01% |
141,566
+3,738
| +3% | +$67.4K |
|
|
SGNT
1615
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.53M | ﹤0.01% |
168,690
+4,518
| +3% | +$67.7K |
|
1616
Tootsie Roll Industries
TR
$2.88B
| $2.52M | ﹤0.01% |
84,994
+10,699
| +14% | +$318K |
|
1617
Movado Group
MOV
$426M
| $2.52M | ﹤0.01% |
116,269
+3,422
| +3% | +$74.2K |
|
1618
Ardmore Shipping
ASC
$502M
| $2.5M | ﹤0.01% |
368,739
-3,583
| -1% | -$24.3K |
|
|
PETX
1619
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.47M | ﹤0.01% |
390,000
-10,000
| -3% | -$63.2K |
|
1620
Phibro Animal Health
PAHC
$1.67B
| $2.45M | ﹤0.01% |
131,421
+4,792
| +4% | +$89.4K |
|
1621
Powell Industries
POWL
$3.34B
| $2.45M | ﹤0.01% |
62,341
+2,440
| +4% | +$96K |
|
1622
REX American Resources
REX
$1.01B
| $2.35M | ﹤0.01% |
117,678
-2,016
| -2% | -$40.2K |
|
|
ICON
1623
DELISTED
Iconix Brand Group, Inc.
ICON
| $2.31M | ﹤0.01% |
34,153
+1,010
| +3% | +$68.3K |
|
|
BKMU
1624
DELISTED
Bank Mutual Corp
BKMU
| $2.29M | ﹤0.01% |
298,098
+7,818
| +3% | +$60K |
|
1625
Vanda Pharmaceuticals
VNDA
$265M
| $2.28M | ﹤0.01% |
203,600
-4,900
| -2% | -$54.8K |
|